Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
SUPERNUS PHARMACEUTICALS, INC. | Director | Common Stock | 17.2 K | $500 K | $29.06 | Feb 23, 2024 | Direct |
SUPERNUS PHARMACEUTICALS, INC. | Director | Restricted Stock Unit | 0 | $0 | $29.06 | Feb 23, 2024 | Direct |
Disc Medicine, Inc. | Director | Stock Option (Right to Buy) | 10 K | Jun 12, 2024 | Direct | ||
SUPERNUS PHARMACEUTICALS, INC. | Director | Director Stock Option (Right to Buy) | 8.25 K | Feb 22, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IRON | Disc Medicine, Inc. | Jun 12, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
SUPN | SUPERNUS PHARMACEUTICALS, INC. | Feb 23, 2024 | 2 | $0 | 4 | Feb 27, 2024 | Director |
SUPN | SUPERNUS PHARMACEUTICALS, INC. | Feb 22, 2024 | 2 | $0 | 4 | Feb 26, 2024 | Director |
IRON | Disc Medicine, Inc. | Jun 9, 2023 | 1 | $0 | 4 | Jun 9, 2023 | Director |
SUPN | SUPERNUS PHARMACEUTICALS, INC. | Feb 23, 2023 | 2 | $0 | 4 | Feb 27, 2023 | Director |
SUPN | SUPERNUS PHARMACEUTICALS, INC. | Feb 22, 2023 | 2 | $0 | 4 | Feb 24, 2023 | Director |
IRON | Disc Medicine, Inc. | Dec 29, 2022 | 1 | $0 | 4 | Jan 3, 2023 | Director |
SUPN | SUPERNUS PHARMACEUTICALS, INC. | Feb 22, 2022 | 2 | $0 | 4 | Feb 24, 2022 | Director |
SUPN | SUPERNUS PHARMACEUTICALS, INC. | Feb 19, 2022 | 2 | $0 | 4 | Feb 23, 2022 | Director |
IRON | Gemini Therapeutics, Inc. /DE | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Executive Chair of the Board, Director |
IRON | Gemini Therapeutics, Inc. /DE | Nov 15, 2021 | 2 | $0 | 4 | Nov 16, 2021 | Executive Chair of the Board of Directors, Director |